11 results
10-K
2023 FY
MIRA
Mira Pharmaceuticals Inc
1 Apr 24
Annual report
7:00am
of which identifies as female, underrepresented minority or LGBTQ+, by December 31, 2026, unless our board of directors is comprised of five or less
424B4
MIRA
Mira Pharmaceuticals Inc
4 Aug 23
Prospectus supplement with pricing info
1:01pm
and the second of which identifies as female, underrepresented minority or LGBTQ+, by December 31, 2026, unless our board of directors is comprised of five
424B1
MIRA
Mira Pharmaceuticals Inc
4 Aug 23
Prospectus with pricing info
12:59pm
one of which identifies as female and the second of which identifies as female, underrepresented minority or LGBTQ+, by December 31, 2026, unless our
S-1
EX-99.4
sus3l
29 Jun 23
IPO registration
4:39pm
S-1
13ugp dnau
29 Jun 23
IPO registration
4:39pm
DRS/A
7ouj c0nvhwsyx
8 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
ffhcc 788
2 May 23
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next